nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—ERBB3—schizophrenia	0.427	0.723	CbGaD
Dasatinib—CYP1A2—schizophrenia	0.106	0.179	CbGaD
Dasatinib—ABCB1—schizophrenia	0.0582	0.0985	CbGaD
Dasatinib—PDGFRA—telencephalon—schizophrenia	0.000419	0.00253	CbGeAlD
Dasatinib—STK36—endocrine gland—schizophrenia	0.000417	0.00252	CbGeAlD
Dasatinib—RIPK2—blood—schizophrenia	0.000416	0.00251	CbGeAlD
Dasatinib—BMPR1B—central nervous system—schizophrenia	0.000414	0.00251	CbGeAlD
Dasatinib—MAP3K19—central nervous system—schizophrenia	0.000414	0.00251	CbGeAlD
Dasatinib—EPHA5—cerebellum—schizophrenia	0.000413	0.0025	CbGeAlD
Dasatinib—SRC—telencephalon—schizophrenia	0.000411	0.00248	CbGeAlD
Dasatinib—STAT5B—brain—schizophrenia	0.00041	0.00248	CbGeAlD
Dasatinib—RIPK2—midbrain—schizophrenia	0.00041	0.00248	CbGeAlD
Dasatinib—TNK2—central nervous system—schizophrenia	0.000406	0.00246	CbGeAlD
Dasatinib—SIK1—blood—schizophrenia	0.000406	0.00245	CbGeAlD
Dasatinib—BMPR1B—cerebellum—schizophrenia	0.000405	0.00245	CbGeAlD
Dasatinib—LIMK2—endocrine gland—schizophrenia	0.000403	0.00244	CbGeAlD
Dasatinib—EPHA4—blood—schizophrenia	0.000402	0.00243	CbGeAlD
Dasatinib—CSF1R—forebrain—schizophrenia	0.000401	0.00242	CbGeAlD
Dasatinib—JAK2—gonad—schizophrenia	0.0004	0.00242	CbGeAlD
Dasatinib—TNK2—cerebellum—schizophrenia	0.000397	0.0024	CbGeAlD
Dasatinib—TESK1—nervous system—schizophrenia	0.000397	0.0024	CbGeAlD
Dasatinib—MAP3K2—blood—schizophrenia	0.000394	0.00238	CbGeAlD
Dasatinib—ERBB3—midbrain—schizophrenia	0.000393	0.00238	CbGeAlD
Dasatinib—STK35—endocrine gland—schizophrenia	0.000391	0.00236	CbGeAlD
Dasatinib—EPHB3—nervous system—schizophrenia	0.00039	0.00236	CbGeAlD
Dasatinib—STK36—nervous system—schizophrenia	0.00039	0.00236	CbGeAlD
Dasatinib—CSK—endocrine gland—schizophrenia	0.000388	0.00235	CbGeAlD
Dasatinib—MAP4K5—gonad—schizophrenia	0.000386	0.00233	CbGeAlD
Dasatinib—MAP3K3—gonad—schizophrenia	0.000386	0.00233	CbGeAlD
Dasatinib—HCK—endocrine gland—schizophrenia	0.000383	0.00232	CbGeAlD
Dasatinib—TESK1—central nervous system—schizophrenia	0.000382	0.00231	CbGeAlD
Dasatinib—EPHA3—brain—schizophrenia	0.000379	0.00229	CbGeAlD
Dasatinib—MAP2K5—telencephalon—schizophrenia	0.000378	0.00228	CbGeAlD
Dasatinib—LIMK2—nervous system—schizophrenia	0.000377	0.00228	CbGeAlD
Dasatinib—STK36—central nervous system—schizophrenia	0.000376	0.00227	CbGeAlD
Dasatinib—EPHB3—central nervous system—schizophrenia	0.000376	0.00227	CbGeAlD
Dasatinib—TESK1—cerebellum—schizophrenia	0.000373	0.00226	CbGeAlD
Dasatinib—MAPK14—blood—schizophrenia	0.00037	0.00224	CbGeAlD
Dasatinib—SIK3—brain—schizophrenia	0.000369	0.00223	CbGeAlD
Dasatinib—FGR—blood—schizophrenia	0.000369	0.00223	CbGeAlD
Dasatinib—LCK—blood—schizophrenia	0.000369	0.00223	CbGeAlD
Dasatinib—CSF1R—telencephalon—schizophrenia	0.000369	0.00223	CbGeAlD
Dasatinib—STK36—cerebellum—schizophrenia	0.000367	0.00222	CbGeAlD
Dasatinib—EPHB3—cerebellum—schizophrenia	0.000367	0.00222	CbGeAlD
Dasatinib—STK35—nervous system—schizophrenia	0.000366	0.00221	CbGeAlD
Dasatinib—CSK—nervous system—schizophrenia	0.000363	0.0022	CbGeAlD
Dasatinib—LIMK2—central nervous system—schizophrenia	0.000363	0.0022	CbGeAlD
Dasatinib—RIPK2—endocrine gland—schizophrenia	0.00036	0.00218	CbGeAlD
Dasatinib—HCK—nervous system—schizophrenia	0.000359	0.00217	CbGeAlD
Dasatinib—YES1—gonad—schizophrenia	0.000356	0.00215	CbGeAlD
Dasatinib—LIMK2—cerebellum—schizophrenia	0.000355	0.00215	CbGeAlD
Dasatinib—STK35—central nervous system—schizophrenia	0.000352	0.00213	CbGeAlD
Dasatinib—SIK1—endocrine gland—schizophrenia	0.000352	0.00213	CbGeAlD
Dasatinib—EPHB4—blood—schizophrenia	0.000351	0.00212	CbGeAlD
Dasatinib—CYP1A2—blood plasma—schizophrenia	0.000351	0.00212	CbGeAlD
Dasatinib—CSK—central nervous system—schizophrenia	0.00035	0.00212	CbGeAlD
Dasatinib—PDGFRA—gonad—schizophrenia	0.000349	0.00211	CbGeAlD
Dasatinib—JAK2—blood—schizophrenia	0.000349	0.00211	CbGeAlD
Dasatinib—EPHA4—endocrine gland—schizophrenia	0.000348	0.00211	CbGeAlD
Dasatinib—EPHB4—midbrain—schizophrenia	0.000347	0.0021	CbGeAlD
Dasatinib—HCK—central nervous system—schizophrenia	0.000345	0.00209	CbGeAlD
Dasatinib—ERBB3—endocrine gland—schizophrenia	0.000345	0.00209	CbGeAlD
Dasatinib—EPHA2—blood—schizophrenia	0.000344	0.00208	CbGeAlD
Dasatinib—STK35—cerebellum—schizophrenia	0.000344	0.00208	CbGeAlD
Dasatinib—FYN—blood—schizophrenia	0.000344	0.00208	CbGeAlD
Dasatinib—ZAK—brain—schizophrenia	0.000343	0.00208	CbGeAlD
Dasatinib—SRC—gonad—schizophrenia	0.000343	0.00207	CbGeAlD
Dasatinib—CSK—cerebellum—schizophrenia	0.000342	0.00207	CbGeAlD
Dasatinib—MAP3K2—endocrine gland—schizophrenia	0.000342	0.00207	CbGeAlD
Dasatinib—FYN—midbrain—schizophrenia	0.00034	0.00205	CbGeAlD
Dasatinib—CYP3A5—blood plasma—schizophrenia	0.000339	0.00205	CbGeAlD
Dasatinib—MAP3K3—blood—schizophrenia	0.000336	0.00203	CbGeAlD
Dasatinib—MAP4K5—blood—schizophrenia	0.000336	0.00203	CbGeAlD
Dasatinib—EPHA5—brain—schizophrenia	0.000336	0.00203	CbGeAlD
Dasatinib—ABL2—cerebellum—schizophrenia	0.000336	0.00203	CbGeAlD
Dasatinib—KIT—telencephalon—schizophrenia	0.000335	0.00202	CbGeAlD
Dasatinib—LYN—brain—schizophrenia	0.000334	0.00202	CbGeAlD
Dasatinib—MAP4K5—midbrain—schizophrenia	0.000332	0.00201	CbGeAlD
Dasatinib—MAP3K3—midbrain—schizophrenia	0.000332	0.00201	CbGeAlD
Dasatinib—SIK1—nervous system—schizophrenia	0.000329	0.00199	CbGeAlD
Dasatinib—BMPR1B—brain—schizophrenia	0.000329	0.00199	CbGeAlD
Dasatinib—MAP3K19—brain—schizophrenia	0.000329	0.00199	CbGeAlD
Dasatinib—BTK—brain—schizophrenia	0.000327	0.00198	CbGeAlD
Dasatinib—PDGFRB—telencephalon—schizophrenia	0.000327	0.00198	CbGeAlD
Dasatinib—EPHA4—nervous system—schizophrenia	0.000326	0.00197	CbGeAlD
Dasatinib—ERBB3—nervous system—schizophrenia	0.000323	0.00195	CbGeAlD
Dasatinib—TNK2—brain—schizophrenia	0.000323	0.00195	CbGeAlD
Dasatinib—MAPK14—endocrine gland—schizophrenia	0.000321	0.00194	CbGeAlD
Dasatinib—EPHB6—blood—schizophrenia	0.000321	0.00194	CbGeAlD
Dasatinib—FGR—endocrine gland—schizophrenia	0.00032	0.00194	CbGeAlD
Dasatinib—MAP3K2—nervous system—schizophrenia	0.00032	0.00193	CbGeAlD
Dasatinib—RIPK2—cerebellum—schizophrenia	0.000317	0.00192	CbGeAlD
Dasatinib—SIK1—central nervous system—schizophrenia	0.000317	0.00192	CbGeAlD
Dasatinib—EPHB6—midbrain—schizophrenia	0.000317	0.00192	CbGeAlD
Dasatinib—EPHA4—central nervous system—schizophrenia	0.000314	0.0019	CbGeAlD
Dasatinib—ERBB3—central nervous system—schizophrenia	0.000311	0.00188	CbGeAlD
Dasatinib—YES1—blood—schizophrenia	0.00031	0.00188	CbGeAlD
Dasatinib—SIK1—cerebellum—schizophrenia	0.00031	0.00188	CbGeAlD
Dasatinib—FMO3—endocrine gland—schizophrenia	0.000309	0.00187	CbGeAlD
Dasatinib—MAP3K2—central nervous system—schizophrenia	0.000308	0.00186	CbGeAlD
Dasatinib—CSF1R—gonad—schizophrenia	0.000308	0.00186	CbGeAlD
Dasatinib—EPHA4—cerebellum—schizophrenia	0.000307	0.00186	CbGeAlD
Dasatinib—YES1—midbrain—schizophrenia	0.000306	0.00185	CbGeAlD
Dasatinib—EPHB4—endocrine gland—schizophrenia	0.000305	0.00184	CbGeAlD
Dasatinib—PDGFRA—blood—schizophrenia	0.000304	0.00184	CbGeAlD
Dasatinib—ERBB3—cerebellum—schizophrenia	0.000304	0.00184	CbGeAlD
Dasatinib—TESK1—brain—schizophrenia	0.000303	0.00183	CbGeAlD
Dasatinib—JAK2—endocrine gland—schizophrenia	0.000302	0.00183	CbGeAlD
Dasatinib—MAP3K2—cerebellum—schizophrenia	0.000301	0.00182	CbGeAlD
Dasatinib—MAPK14—nervous system—schizophrenia	0.000301	0.00182	CbGeAlD
Dasatinib—FGR—nervous system—schizophrenia	0.000299	0.00181	CbGeAlD
Dasatinib—EPHA2—endocrine gland—schizophrenia	0.000299	0.00181	CbGeAlD
Dasatinib—SRC—blood—schizophrenia	0.000299	0.00181	CbGeAlD
Dasatinib—EPHB3—brain—schizophrenia	0.000298	0.00181	CbGeAlD
Dasatinib—STK36—brain—schizophrenia	0.000298	0.00181	CbGeAlD
Dasatinib—FYN—endocrine gland—schizophrenia	0.000298	0.0018	CbGeAlD
Dasatinib—MAP3K3—endocrine gland—schizophrenia	0.000291	0.00176	CbGeAlD
Dasatinib—MAP4K5—endocrine gland—schizophrenia	0.000291	0.00176	CbGeAlD
Dasatinib—ABL1—telencephalon—schizophrenia	0.000291	0.00176	CbGeAlD
Dasatinib—MAPK14—central nervous system—schizophrenia	0.00029	0.00175	CbGeAlD
Dasatinib—FMO3—nervous system—schizophrenia	0.000289	0.00175	CbGeAlD
Dasatinib—LIMK2—brain—schizophrenia	0.000289	0.00175	CbGeAlD
Dasatinib—FGR—central nervous system—schizophrenia	0.000288	0.00174	CbGeAlD
Dasatinib—JAK2—nervous system—schizophrenia	0.000283	0.00171	CbGeAlD
Dasatinib—MAPK14—cerebellum—schizophrenia	0.000283	0.00171	CbGeAlD
Dasatinib—STK35—brain—schizophrenia	0.00028	0.00169	CbGeAlD
Dasatinib—EPHA2—nervous system—schizophrenia	0.00028	0.00169	CbGeAlD
Dasatinib—KIT—gonad—schizophrenia	0.000279	0.00169	CbGeAlD
Dasatinib—FYN—nervous system—schizophrenia	0.000279	0.00169	CbGeAlD
Dasatinib—FMO3—central nervous system—schizophrenia	0.000278	0.00168	CbGeAlD
Dasatinib—CSK—brain—schizophrenia	0.000278	0.00168	CbGeAlD
Dasatinib—MAP2K5—blood—schizophrenia	0.000275	0.00166	CbGeAlD
Dasatinib—HCK—brain—schizophrenia	0.000274	0.00166	CbGeAlD
Dasatinib—PDGFRB—gonad—schizophrenia	0.000273	0.00165	CbGeAlD
Dasatinib—MAP4K5—nervous system—schizophrenia	0.000273	0.00165	CbGeAlD
Dasatinib—MAP3K3—nervous system—schizophrenia	0.000273	0.00165	CbGeAlD
Dasatinib—ABL2—brain—schizophrenia	0.000273	0.00165	CbGeAlD
Dasatinib—JAK2—central nervous system—schizophrenia	0.000273	0.00165	CbGeAlD
Dasatinib—MAP2K5—midbrain—schizophrenia	0.000271	0.00164	CbGeAlD
Dasatinib—EPHA2—central nervous system—schizophrenia	0.000269	0.00163	CbGeAlD
Dasatinib—YES1—endocrine gland—schizophrenia	0.000269	0.00163	CbGeAlD
Dasatinib—FYN—central nervous system—schizophrenia	0.000269	0.00163	CbGeAlD
Dasatinib—EPHB4—cerebellum—schizophrenia	0.000268	0.00162	CbGeAlD
Dasatinib—CSF1R—blood—schizophrenia	0.000268	0.00162	CbGeAlD
Dasatinib—JAK2—cerebellum—schizophrenia	0.000266	0.00161	CbGeAlD
Dasatinib—CSF1R—midbrain—schizophrenia	0.000265	0.0016	CbGeAlD
Dasatinib—PDGFRA—endocrine gland—schizophrenia	0.000264	0.0016	CbGeAlD
Dasatinib—FYN—cerebellum—schizophrenia	0.000263	0.00159	CbGeAlD
Dasatinib—MAP3K3—central nervous system—schizophrenia	0.000263	0.00159	CbGeAlD
Dasatinib—MAP4K5—central nervous system—schizophrenia	0.000263	0.00159	CbGeAlD
Dasatinib—EPHB6—nervous system—schizophrenia	0.000261	0.00158	CbGeAlD
Dasatinib—SRC—endocrine gland—schizophrenia	0.000259	0.00157	CbGeAlD
Dasatinib—RIPK2—brain—schizophrenia	0.000258	0.00156	CbGeAlD
Dasatinib—MAP3K3—cerebellum—schizophrenia	0.000257	0.00155	CbGeAlD
Dasatinib—MAP4K5—cerebellum—schizophrenia	0.000257	0.00155	CbGeAlD
Dasatinib—CYP3A4—blood plasma—schizophrenia	0.000254	0.00154	CbGeAlD
Dasatinib—YES1—nervous system—schizophrenia	0.000252	0.00152	CbGeAlD
Dasatinib—SIK1—brain—schizophrenia	0.000252	0.00152	CbGeAlD
Dasatinib—EPHB6—central nervous system—schizophrenia	0.000251	0.00152	CbGeAlD
Dasatinib—EPHA4—brain—schizophrenia	0.000249	0.00151	CbGeAlD
Dasatinib—PDGFRA—nervous system—schizophrenia	0.000247	0.0015	CbGeAlD
Dasatinib—ERBB3—brain—schizophrenia	0.000247	0.00149	CbGeAlD
Dasatinib—CYP1B1—telencephalon—schizophrenia	0.000247	0.00149	CbGeAlD
Dasatinib—EPHB6—cerebellum—schizophrenia	0.000245	0.00148	CbGeAlD
Dasatinib—MAP3K2—brain—schizophrenia	0.000244	0.00148	CbGeAlD
Dasatinib—KIT—blood—schizophrenia	0.000243	0.00147	CbGeAlD
Dasatinib—ABL1—gonad—schizophrenia	0.000243	0.00147	CbGeAlD
Dasatinib—YES1—central nervous system—schizophrenia	0.000243	0.00147	CbGeAlD
Dasatinib—SRC—nervous system—schizophrenia	0.000242	0.00147	CbGeAlD
Dasatinib—KIT—midbrain—schizophrenia	0.00024	0.00145	CbGeAlD
Dasatinib—MAP2K5—endocrine gland—schizophrenia	0.000238	0.00144	CbGeAlD
Dasatinib—PDGFRA—central nervous system—schizophrenia	0.000238	0.00144	CbGeAlD
Dasatinib—PDGFRB—blood—schizophrenia	0.000238	0.00144	CbGeAlD
Dasatinib—YES1—cerebellum—schizophrenia	0.000237	0.00143	CbGeAlD
Dasatinib—PDGFRB—midbrain—schizophrenia	0.000235	0.00142	CbGeAlD
Dasatinib—SRC—central nervous system—schizophrenia	0.000233	0.00141	CbGeAlD
Dasatinib—PDGFRA—cerebellum—schizophrenia	0.000233	0.00141	CbGeAlD
Dasatinib—CSF1R—endocrine gland—schizophrenia	0.000232	0.00141	CbGeAlD
Dasatinib—MAPK14—brain—schizophrenia	0.00023	0.00139	CbGeAlD
Dasatinib—FGR—brain—schizophrenia	0.000229	0.00138	CbGeAlD
Dasatinib—SRC—cerebellum—schizophrenia	0.000228	0.00138	CbGeAlD
Dasatinib—MAP2K5—nervous system—schizophrenia	0.000223	0.00135	CbGeAlD
Dasatinib—FMO3—brain—schizophrenia	0.000221	0.00134	CbGeAlD
Dasatinib—EPHB4—brain—schizophrenia	0.000218	0.00132	CbGeAlD
Dasatinib—CSF1R—nervous system—schizophrenia	0.000218	0.00132	CbGeAlD
Dasatinib—JAK2—brain—schizophrenia	0.000216	0.00131	CbGeAlD
Dasatinib—MAP2K5—central nervous system—schizophrenia	0.000215	0.0013	CbGeAlD
Dasatinib—EPHA2—brain—schizophrenia	0.000214	0.00129	CbGeAlD
Dasatinib—FYN—brain—schizophrenia	0.000213	0.00129	CbGeAlD
Dasatinib—ABL1—blood—schizophrenia	0.000212	0.00128	CbGeAlD
Dasatinib—KIT—endocrine gland—schizophrenia	0.000211	0.00128	CbGeAlD
Dasatinib—MAP2K5—cerebellum—schizophrenia	0.00021	0.00127	CbGeAlD
Dasatinib—CSF1R—central nervous system—schizophrenia	0.00021	0.00127	CbGeAlD
Dasatinib—ABL1—midbrain—schizophrenia	0.000209	0.00127	CbGeAlD
Dasatinib—MAP4K5—brain—schizophrenia	0.000209	0.00126	CbGeAlD
Dasatinib—MAP3K3—brain—schizophrenia	0.000209	0.00126	CbGeAlD
Dasatinib—PDGFRB—endocrine gland—schizophrenia	0.000206	0.00125	CbGeAlD
Dasatinib—CYP1B1—gonad—schizophrenia	0.000206	0.00125	CbGeAlD
Dasatinib—CSF1R—cerebellum—schizophrenia	0.000205	0.00124	CbGeAlD
Dasatinib—EPHB6—brain—schizophrenia	0.000199	0.00121	CbGeAlD
Dasatinib—KIT—nervous system—schizophrenia	0.000198	0.0012	CbGeAlD
Dasatinib—PDGFRB—nervous system—schizophrenia	0.000193	0.00117	CbGeAlD
Dasatinib—YES1—brain—schizophrenia	0.000193	0.00116	CbGeAlD
Dasatinib—KIT—central nervous system—schizophrenia	0.00019	0.00115	CbGeAlD
Dasatinib—PDGFRA—brain—schizophrenia	0.000189	0.00114	CbGeAlD
Dasatinib—KIT—cerebellum—schizophrenia	0.000186	0.00112	CbGeAlD
Dasatinib—PDGFRB—central nervous system—schizophrenia	0.000186	0.00112	CbGeAlD
Dasatinib—SRC—brain—schizophrenia	0.000185	0.00112	CbGeAlD
Dasatinib—ABL1—endocrine gland—schizophrenia	0.000184	0.00111	CbGeAlD
Dasatinib—ABCG2—telencephalon—schizophrenia	0.000184	0.00111	CbGeAlD
Dasatinib—PDGFRB—cerebellum—schizophrenia	0.000182	0.0011	CbGeAlD
Dasatinib—ABCB1—blood plasma—schizophrenia	0.00018	0.00109	CbGeAlD
Dasatinib—CYP1B1—blood—schizophrenia	0.000179	0.00109	CbGeAlD
Dasatinib—ABL1—nervous system—schizophrenia	0.000172	0.00104	CbGeAlD
Dasatinib—MAP2K5—brain—schizophrenia	0.00017	0.00103	CbGeAlD
Dasatinib—CSF1R—brain—schizophrenia	0.000166	0.00101	CbGeAlD
Dasatinib—ABL1—central nervous system—schizophrenia	0.000166	0.001	CbGeAlD
Dasatinib—ABL1—cerebellum—schizophrenia	0.000162	0.000979	CbGeAlD
Dasatinib—CYP1B1—endocrine gland—schizophrenia	0.000156	0.000941	CbGeAlD
Dasatinib—KIT—brain—schizophrenia	0.000151	0.000914	CbGeAlD
Dasatinib—PDGFRB—brain—schizophrenia	0.000148	0.000892	CbGeAlD
Dasatinib—CYP1B1—nervous system—schizophrenia	0.000146	0.000881	CbGeAlD
Dasatinib—CYP1B1—central nervous system—schizophrenia	0.00014	0.000848	CbGeAlD
Dasatinib—CYP1B1—cerebellum—schizophrenia	0.000137	0.000829	CbGeAlD
Dasatinib—ABCG2—blood—schizophrenia	0.000134	0.000808	CbGeAlD
Dasatinib—ABCG2—midbrain—schizophrenia	0.000132	0.000798	CbGeAlD
Dasatinib—ABL1—brain—schizophrenia	0.000131	0.000795	CbGeAlD
Dasatinib—CYP1A2—blood—schizophrenia	0.000129	0.000778	CbGeAlD
Dasatinib—CYP1A1—blood—schizophrenia	0.000127	0.000767	CbGeAlD
Dasatinib—CYP3A5—blood—schizophrenia	0.000124	0.00075	CbGeAlD
Dasatinib—CYP1A2—endocrine gland—schizophrenia	0.000112	0.000675	CbGeAlD
Dasatinib—CYP1B1—brain—schizophrenia	0.000111	0.000673	CbGeAlD
Dasatinib—CYP1A1—endocrine gland—schizophrenia	0.00011	0.000665	CbGeAlD
Dasatinib—CYP3A5—endocrine gland—schizophrenia	0.000108	0.000651	CbGeAlD
Dasatinib—CYP1A1—nervous system—schizophrenia	0.000103	0.000623	CbGeAlD
Dasatinib—ABCG2—cerebellum—schizophrenia	0.000102	0.000617	CbGeAlD
Dasatinib—CYP1A1—central nervous system—schizophrenia	9.91e-05	0.0006	CbGeAlD
Dasatinib—ABCB1—forebrain—schizophrenia	9.85e-05	0.000596	CbGeAlD
Dasatinib—CYP3A4—blood—schizophrenia	9.31e-05	0.000563	CbGeAlD
Dasatinib—ABCB1—telencephalon—schizophrenia	9.06e-05	0.000548	CbGeAlD
Dasatinib—ABCG2—brain—schizophrenia	8.29e-05	0.000501	CbGeAlD
Dasatinib—CYP3A4—endocrine gland—schizophrenia	8.07e-05	0.000488	CbGeAlD
Dasatinib—CYP1A1—brain—schizophrenia	7.87e-05	0.000476	CbGeAlD
Dasatinib—ABCB1—gonad—schizophrenia	7.56e-05	0.000457	CbGeAlD
Dasatinib—CYP3A4—nervous system—schizophrenia	7.56e-05	0.000457	CbGeAlD
Dasatinib—CYP3A4—central nervous system—schizophrenia	7.27e-05	0.00044	CbGeAlD
Dasatinib—ABCB1—blood—schizophrenia	6.59e-05	0.000399	CbGeAlD
Dasatinib—ABCB1—midbrain—schizophrenia	6.51e-05	0.000394	CbGeAlD
Dasatinib—ABCB1—endocrine gland—schizophrenia	5.71e-05	0.000346	CbGeAlD
Dasatinib—ABCB1—nervous system—schizophrenia	5.35e-05	0.000324	CbGeAlD
Dasatinib—ABCB1—central nervous system—schizophrenia	5.15e-05	0.000311	CbGeAlD
Dasatinib—ABCB1—cerebellum—schizophrenia	5.03e-05	0.000304	CbGeAlD
Dasatinib—ABCB1—brain—schizophrenia	4.09e-05	0.000247	CbGeAlD
Dasatinib—RIPK2—Signaling Pathways—EP300—schizophrenia	2.3e-06	9.43e-06	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—TP53—schizophrenia	2.29e-06	9.42e-06	CbGpPWpGaD
Dasatinib—LYN—Immune System—IL1B—schizophrenia	2.29e-06	9.42e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—APOE—schizophrenia	2.29e-06	9.4e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—GSK3B—schizophrenia	2.29e-06	9.38e-06	CbGpPWpGaD
Dasatinib—MAPK14—Developmental Biology—AKT1—schizophrenia	2.28e-06	9.38e-06	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IL1B—schizophrenia	2.28e-06	9.37e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—S100B—schizophrenia	2.28e-06	9.37e-06	CbGpPWpGaD
Dasatinib—HCK—Immune System—AKT1—schizophrenia	2.28e-06	9.36e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NRG1—schizophrenia	2.28e-06	9.34e-06	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—TP53—schizophrenia	2.28e-06	9.34e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—ESR1—schizophrenia	2.27e-06	9.31e-06	CbGpPWpGaD
Dasatinib—KIT—Disease—EP300—schizophrenia	2.27e-06	9.31e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—APOA1—schizophrenia	2.27e-06	9.3e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—GSK3B—schizophrenia	2.26e-06	9.28e-06	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL1B—schizophrenia	2.26e-06	9.27e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MEF2C—schizophrenia	2.26e-06	9.26e-06	CbGpPWpGaD
Dasatinib—JAK2—Developmental Biology—AKT1—schizophrenia	2.26e-06	9.26e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—FOS—schizophrenia	2.25e-06	9.22e-06	CbGpPWpGaD
Dasatinib—MAPK14—Hemostasis—AKT1—schizophrenia	2.24e-06	9.2e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—ESR1—schizophrenia	2.22e-06	9.12e-06	CbGpPWpGaD
Dasatinib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	2.21e-06	9.08e-06	CbGpPWpGaD
Dasatinib—JAK2—Hemostasis—AKT1—schizophrenia	2.21e-06	9.08e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—APOE—schizophrenia	2.21e-06	9.07e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—APOE—schizophrenia	2.21e-06	9.06e-06	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—TP53—schizophrenia	2.2e-06	9.04e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—ESR1—schizophrenia	2.19e-06	8.98e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—APOA1—schizophrenia	2.18e-06	8.97e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—ERBB4—schizophrenia	2.18e-06	8.96e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—APOA1—schizophrenia	2.18e-06	8.95e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—YWHAZ—schizophrenia	2.18e-06	8.95e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—APOE—schizophrenia	2.18e-06	8.94e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL1B—schizophrenia	2.18e-06	8.93e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Innate Immune System—AKT1—schizophrenia	2.17e-06	8.92e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GAPDH—schizophrenia	2.17e-06	8.89e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—APOA1—schizophrenia	2.15e-06	8.84e-06	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—AKT1—schizophrenia	2.15e-06	8.82e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL1B—schizophrenia	2.15e-06	8.81e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—EP300—schizophrenia	2.15e-06	8.81e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CLOCK—schizophrenia	2.15e-06	8.81e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—schizophrenia	2.14e-06	8.79e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—ERBB3—schizophrenia	2.13e-06	8.75e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GCLM—schizophrenia	2.13e-06	8.75e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—TPH1—schizophrenia	2.13e-06	8.75e-06	CbGpPWpGaD
Dasatinib—LYN—Innate Immune System—AKT1—schizophrenia	2.13e-06	8.74e-06	CbGpPWpGaD
Dasatinib—ABL1—Innate Immune System—AKT1—schizophrenia	2.12e-06	8.7e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	2.12e-06	8.69e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—ESR1—schizophrenia	2.11e-06	8.65e-06	CbGpPWpGaD
Dasatinib—HCK—Disease—AKT1—schizophrenia	2.11e-06	8.64e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—COMT—schizophrenia	2.1e-06	8.64e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—EP300—schizophrenia	2.1e-06	8.63e-06	CbGpPWpGaD
Dasatinib—FYN—Innate Immune System—AKT1—schizophrenia	2.1e-06	8.6e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—EP300—schizophrenia	2.1e-06	8.6e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—SNAP25—schizophrenia	2.1e-06	8.6e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CYP2D6—schizophrenia	2.1e-06	8.6e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—GSTP1—schizophrenia	2.09e-06	8.6e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—TPH2—schizophrenia	2.09e-06	8.59e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CACNB2—schizophrenia	2.09e-06	8.59e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—MAOA—schizophrenia	2.09e-06	8.58e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—GSK3B—schizophrenia	2.09e-06	8.57e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Adaptive Immune System—AKT1—schizophrenia	2.09e-06	8.57e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—ESR1—schizophrenia	2.08e-06	8.53e-06	CbGpPWpGaD
Dasatinib—BLK—Immune System—AKT1—schizophrenia	2.07e-06	8.48e-06	CbGpPWpGaD
Dasatinib—FGR—Immune System—AKT1—schizophrenia	2.06e-06	8.45e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—GSK3B—schizophrenia	2.06e-06	8.45e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—DPYD—schizophrenia	2.06e-06	8.45e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—PLA2G4A—schizophrenia	2.05e-06	8.42e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—HTR2A—schizophrenia	2.05e-06	8.42e-06	CbGpPWpGaD
Dasatinib—LYN—Immune System—EP300—schizophrenia	2.05e-06	8.42e-06	CbGpPWpGaD
Dasatinib—LYN—Adaptive Immune System—AKT1—schizophrenia	2.04e-06	8.39e-06	CbGpPWpGaD
Dasatinib—ABL1—Immune System—EP300—schizophrenia	2.04e-06	8.38e-06	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—TP53—schizophrenia	2.03e-06	8.34e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—EP300—schizophrenia	2.03e-06	8.32e-06	CbGpPWpGaD
Dasatinib—FYN—Immune System—EP300—schizophrenia	2.02e-06	8.29e-06	CbGpPWpGaD
Dasatinib—MAPK14—Innate Immune System—AKT1—schizophrenia	2.02e-06	8.28e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—GSK3B—schizophrenia	2.02e-06	8.27e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NRG1—schizophrenia	2.01e-06	8.27e-06	CbGpPWpGaD
Dasatinib—FYN—Adaptive Immune System—AKT1—schizophrenia	2.01e-06	8.26e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PRKD1—schizophrenia	2e-06	8.22e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MEF2C—schizophrenia	2e-06	8.2e-06	CbGpPWpGaD
Dasatinib—JAK2—Innate Immune System—AKT1—schizophrenia	1.99e-06	8.18e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—COMT—schizophrenia	1.99e-06	8.16e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—GSK3B—schizophrenia	1.98e-06	8.14e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—ABCB1—schizophrenia	1.98e-06	8.14e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—GSTP1—schizophrenia	1.98e-06	8.12e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—MAOA—schizophrenia	1.97e-06	8.1e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—EP300—schizophrenia	1.94e-06	7.98e-06	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—AKT1—schizophrenia	1.94e-06	7.95e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—EP300—schizophrenia	1.93e-06	7.94e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—YWHAZ—schizophrenia	1.93e-06	7.92e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PLA2G4A—schizophrenia	1.92e-06	7.9e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—GSTM1—schizophrenia	1.92e-06	7.9e-06	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—AKT1—schizophrenia	1.92e-06	7.89e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—EP300—schizophrenia	1.92e-06	7.88e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism of lipids and lipoproteins—EP300—schizophrenia	1.91e-06	7.86e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CACNA1C—schizophrenia	1.91e-06	7.85e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—GSK3B—schizophrenia	1.91e-06	7.84e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—APOE—schizophrenia	1.91e-06	7.83e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CYP1A2—schizophrenia	1.9e-06	7.78e-06	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—AKT1—schizophrenia	1.89e-06	7.77e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—ERBB3—schizophrenia	1.89e-06	7.75e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—GSK3B—schizophrenia	1.89e-06	7.74e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—APOA1—schizophrenia	1.89e-06	7.74e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL1B—schizophrenia	1.88e-06	7.72e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—ABCB1—schizophrenia	1.87e-06	7.69e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—TH—schizophrenia	1.87e-06	7.66e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PIK3C2A—schizophrenia	1.87e-06	7.65e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—EP300—schizophrenia	1.86e-06	7.65e-06	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—AKT1—schizophrenia	1.86e-06	7.65e-06	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—AKT1—schizophrenia	1.86e-06	7.64e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—ESR1—schizophrenia	1.82e-06	7.48e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PLA2G4A—schizophrenia	1.82e-06	7.46e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—GSTM1—schizophrenia	1.82e-06	7.46e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—HTR2A—schizophrenia	1.82e-06	7.46e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—EP300—schizophrenia	1.78e-06	7.3e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—EP300—schizophrenia	1.77e-06	7.27e-06	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—AKT1—schizophrenia	1.75e-06	7.18e-06	CbGpPWpGaD
Dasatinib—ERBB3—Disease—AKT1—schizophrenia	1.75e-06	7.18e-06	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—AKT1—schizophrenia	1.74e-06	7.16e-06	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—AKT1—schizophrenia	1.72e-06	7.04e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—MTHFR—schizophrenia	1.7e-06	6.98e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—APOE—schizophrenia	1.69e-06	6.93e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—EP300—schizophrenia	1.68e-06	6.9e-06	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—AKT1—schizophrenia	1.68e-06	6.88e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—SNAP25—schizophrenia	1.67e-06	6.87e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CYP2D6—schizophrenia	1.67e-06	6.87e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GAPDH—schizophrenia	1.67e-06	6.86e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—APOA1—schizophrenia	1.67e-06	6.85e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL1B—schizophrenia	1.67e-06	6.83e-06	CbGpPWpGaD
Dasatinib—YES1—Immune System—AKT1—schizophrenia	1.66e-06	6.82e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CLOCK—schizophrenia	1.66e-06	6.8e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—GSK3B—schizophrenia	1.65e-06	6.78e-06	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—TP53—schizophrenia	1.65e-06	6.75e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—TPH2—schizophrenia	1.61e-06	6.63e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CACNB2—schizophrenia	1.61e-06	6.63e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—ESR1—schizophrenia	1.61e-06	6.62e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—MTHFR—schizophrenia	1.61e-06	6.6e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—DPYD—schizophrenia	1.59e-06	6.52e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—EP300—schizophrenia	1.59e-06	6.52e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—COMT—schizophrenia	1.59e-06	6.52e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—APOE—schizophrenia	1.58e-06	6.5e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GSTP1—schizophrenia	1.58e-06	6.49e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—MAOA—schizophrenia	1.58e-06	6.47e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—APOA1—schizophrenia	1.57e-06	6.42e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—EP300—schizophrenia	1.55e-06	6.37e-06	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—AKT1—schizophrenia	1.54e-06	6.34e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—TP53—schizophrenia	1.5e-06	6.17e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—EP300—schizophrenia	1.5e-06	6.17e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—APOE—schizophrenia	1.5e-06	6.14e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—TH—schizophrenia	1.49e-06	6.12e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—EP300—schizophrenia	1.49e-06	6.11e-06	CbGpPWpGaD
Dasatinib—KIT—Immune System—AKT1—schizophrenia	1.48e-06	6.09e-06	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—AKT1—schizophrenia	1.48e-06	6.09e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—APOA1—schizophrenia	1.48e-06	6.07e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CACNA1C—schizophrenia	1.48e-06	6.06e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—GSK3B—schizophrenia	1.46e-06	6e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PLA2G4A—schizophrenia	1.45e-06	5.96e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GSTM1—schizophrenia	1.45e-06	5.96e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—TP53—schizophrenia	1.45e-06	5.95e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PIK3C2A—schizophrenia	1.44e-06	5.91e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—AKT1—schizophrenia	1.41e-06	5.77e-06	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—AKT1—schizophrenia	1.4e-06	5.74e-06	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—AKT1—schizophrenia	1.39e-06	5.7e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—EP300—schizophrenia	1.38e-06	5.68e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—EP300—schizophrenia	1.37e-06	5.64e-06	CbGpPWpGaD
Dasatinib—KIT—Disease—AKT1—schizophrenia	1.37e-06	5.63e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—EP300—schizophrenia	1.35e-06	5.56e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—EP300—schizophrenia	1.33e-06	5.44e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—EP300—schizophrenia	1.31e-06	5.36e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—AKT1—schizophrenia	1.3e-06	5.33e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—SNAP25—schizophrenia	1.29e-06	5.3e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CYP2D6—schizophrenia	1.29e-06	5.3e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—MTHFR—schizophrenia	1.28e-06	5.27e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—TP53—schizophrenia	1.27e-06	5.22e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—AKT1—schizophrenia	1.27e-06	5.21e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—AKT1—schizophrenia	1.27e-06	5.21e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—COMT—schizophrenia	1.27e-06	5.2e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—AKT1—schizophrenia	1.27e-06	5.2e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GSTP1—schizophrenia	1.26e-06	5.18e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—EP300—schizophrenia	1.26e-06	5.17e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—MAOA—schizophrenia	1.26e-06	5.17e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—EP300—schizophrenia	1.26e-06	5.16e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—EP300—schizophrenia	1.24e-06	5.09e-06	CbGpPWpGaD
Dasatinib—LYN—Immune System—AKT1—schizophrenia	1.24e-06	5.09e-06	CbGpPWpGaD
Dasatinib—ABL1—Immune System—AKT1—schizophrenia	1.23e-06	5.06e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—AKT1—schizophrenia	1.22e-06	5.03e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—schizophrenia	1.22e-06	5.01e-06	CbGpPWpGaD
Dasatinib—FYN—Immune System—AKT1—schizophrenia	1.22e-06	5.01e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—APOE—schizophrenia	1.2e-06	4.9e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ABCB1—schizophrenia	1.19e-06	4.9e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—APOA1—schizophrenia	1.18e-06	4.85e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—AKT1—schizophrenia	1.18e-06	4.82e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—AKT1—schizophrenia	1.17e-06	4.8e-06	CbGpPWpGaD
Dasatinib—MAPK14—Gene Expression—AKT1—schizophrenia	1.17e-06	4.8e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CYP1A2—schizophrenia	1.17e-06	4.79e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—AKT1—schizophrenia	1.16e-06	4.76e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PLA2G4A—schizophrenia	1.16e-06	4.76e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GSTM1—schizophrenia	1.16e-06	4.76e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—TH—schizophrenia	1.15e-06	4.72e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TP53—schizophrenia	1.14e-06	4.67e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—AKT1—schizophrenia	1.13e-06	4.62e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—EP300—schizophrenia	1.09e-06	4.46e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TP53—schizophrenia	1.08e-06	4.42e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—AKT1—schizophrenia	1.07e-06	4.41e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—AKT1—schizophrenia	1.07e-06	4.4e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—MTHFR—schizophrenia	1.02e-06	4.21e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—AKT1—schizophrenia	1.02e-06	4.17e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—COMT—schizophrenia	9.78e-07	4.02e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GSTP1—schizophrenia	9.74e-07	4e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—MAOA—schizophrenia	9.71e-07	3.99e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TP53—schizophrenia	9.7e-07	3.98e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—EP300—schizophrenia	9.62e-07	3.95e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—AKT1—schizophrenia	9.6e-07	3.94e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—APOE—schizophrenia	9.54e-07	3.92e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TP53—schizophrenia	9.49e-07	3.9e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—APOA1—schizophrenia	9.43e-07	3.87e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—AKT1—schizophrenia	9.38e-07	3.85e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TP53—schizophrenia	9.35e-07	3.84e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ABCB1—schizophrenia	9.22e-07	3.78e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—AKT1—schizophrenia	9.09e-07	3.73e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—EP300—schizophrenia	9.02e-07	3.7e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TP53—schizophrenia	9e-07	3.69e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—AKT1—schizophrenia	9e-07	3.69e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PLA2G4A—schizophrenia	8.95e-07	3.67e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GSTM1—schizophrenia	8.95e-07	3.67e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TP53—schizophrenia	8.88e-07	3.65e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—EP300—schizophrenia	8.53e-07	3.5e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—AKT1—schizophrenia	8.37e-07	3.43e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—AKT1—schizophrenia	8.31e-07	3.41e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—AKT1—schizophrenia	8.19e-07	3.36e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—AKT1—schizophrenia	8.02e-07	3.29e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—MTHFR—schizophrenia	7.91e-07	3.25e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—AKT1—schizophrenia	7.89e-07	3.24e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TP53—schizophrenia	7.78e-07	3.19e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—AKT1—schizophrenia	7.61e-07	3.12e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—AKT1—schizophrenia	7.6e-07	3.12e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—AKT1—schizophrenia	7.5e-07	3.08e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—APOE—schizophrenia	7.36e-07	3.02e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—APOA1—schizophrenia	7.28e-07	2.99e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TP53—schizophrenia	6.89e-07	2.83e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—EP300—schizophrenia	6.81e-07	2.79e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—AKT1—schizophrenia	6.57e-07	2.7e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—AKT1—schizophrenia	5.82e-07	2.39e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—AKT1—schizophrenia	5.45e-07	2.24e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—EP300—schizophrenia	5.44e-07	2.23e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—AKT1—schizophrenia	5.15e-07	2.11e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—EP300—schizophrenia	4.2e-07	1.72e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—AKT1—schizophrenia	4.12e-07	1.69e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—AKT1—schizophrenia	3.29e-07	1.35e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—AKT1—schizophrenia	2.54e-07	1.04e-06	CbGpPWpGaD
